BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10583050)

  • 1. The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration.
    Parslew R; Friedmann PS
    Br J Dermatol; 1999 Sep; 141(3):469-74. PubMed ID: 10583050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing.
    Brandt H; Mustakallio KK
    Acta Derm Venereol; 1983; 63(3):237-40. PubMed ID: 6192640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy.
    Lawrence CM; Finnen MJ; Shuster S
    Br J Dermatol; 1984 Jun; 110(6):671-5. PubMed ID: 6733038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of coal tar on cignolin erythema--1 hour treatment of psoriasis with high-dose cignolin with and without tar].
    Schauder S; Mahrle G
    Z Hautkr; 1985 Jun; 60(11):875-83. PubMed ID: 3160177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
    Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
    Schulze HJ; Schauder S; Mahrle G; Steigleder GK
    J Am Acad Dermatol; 1987 Jul; 17(1):19-24. PubMed ID: 3611453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of psoriasis with dithranol cream compared with dithranol paste.
    Young E
    Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between skin type and erythemal response to anthralin.
    Maurice PD; Greaves MW
    Br J Dermatol; 1983 Sep; 109(3):337-41. PubMed ID: 6615720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short contact anthralin in the treatment of psoriasis: a study of different contact times.
    MacDonald KJ; Marks J
    Br J Dermatol; 1986 Feb; 114(2):235-9. PubMed ID: 3947539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irritation and staining by dithranol (anthralin) and butantrone (10-butyryl dithranol): further short contact and tape stripping experiments.
    Göransson A
    Acta Derm Venereol; 1987; 67(1):72-6. PubMed ID: 2436419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound description and quantification of irritant reactions induced by dithranol at different concentrations. A comparison with visual assessment and colorimetric measurements.
    Schiavi ME; Belletti B; Seidenari S
    Contact Dermatitis; 1996 Apr; 34(4):272-7. PubMed ID: 8730166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classical topical therapy of psoriasis].
    Gerdes S; Mrowietz U
    Hautarzt; 2006 Aug; 57(8):666-71. PubMed ID: 16841204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of psoriasis with dithranol.
    Farber EM
    Acta Derm Venereol Suppl (Stockh); 1984; 112():11-6. PubMed ID: 6596820
    [No Abstract]   [Full Text] [Related]  

  • 14. Irritation and staining by dithranol (anthralin) and related compounds. V. Short-contact and tape-stripping experiments with dithranol and butantrone.
    Göransson AM; Kolari PJ; Mustakallio KK
    Acta Derm Venereol; 1984; 64(2):134-9. PubMed ID: 6203301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical anthralin for psoriasis vulgaris: evaluation of 70 Japanese patients.
    Yamamoto T; Matsuuchi M; Irimajiri J; Otoyama K; Nishioka K
    J Dermatol; 2000 Jul; 27(7):482-5. PubMed ID: 10935350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of low-strength anthralin in psoriasis. A paired comparison study.
    Marley WM; Hernandez AD; Josephs JA; Dawkins L
    Arch Dermatol; 1982 Nov; 118(11):906-8. PubMed ID: 7138048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritation and staining by dithranol (anthralin) and related compounds. IV. Visual estimation of erythema compared with contact thermometry and laser Doppler flowmetry.
    Mustakallio KK; Kolari PJ
    Acta Derm Venereol; 1983; 63(6):513-8. PubMed ID: 6198841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
    Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
    Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.